Transcriptional and Metabolic Investigation in 5'-Nucleotidase Deficient Cancer Cell Lines.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 10 2021
Historique:
received: 20 09 2021
revised: 20 10 2021
accepted: 26 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 4 1 2022
Statut: epublish

Résumé

Enzymes of nucleoside and nucleotide metabolism regulate important cellular processes with potential impacts on nucleotide-unrelated parameters. We have used a set of CRISPR/Cas9-modified cell models expressing both, one, or none of the 5'-nucleotidases cN-II and CD73, together with RNA sequencing and targeted metabolomics, to decipher new regulatory roles of these proteins. We observed important transcriptional modifications between models as well as upon exposure to adenosine. Metabolite content varied differently between cell models in response to adenosine exposure but was rather similar in control conditions. Our original cell models allowed us to identify a new unobvious link between proteins in the nucleotide metabolism and other cellular pathways. Further analyses of our models, including additional experiments, could help us to better understand some of the roles played by these enzymes.

Identifiants

pubmed: 34831141
pii: cells10112918
doi: 10.3390/cells10112918
pmc: PMC8616413
pii:
doi:

Substances chimiques

RNA, Messenger 0
Adenosine Monophosphate 415SHH325A
5'-Nucleotidase EC 3.1.3.5
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ligue Contre le Cancer
ID : NA
Organisme : French National Cancer Institute
ID : INCa_11560
Organisme : Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning
ID : NA

Références

Oncotarget. 2017 Jun 27;8(40):67380-67393
pubmed: 28978040
Biochem Pharmacol. 2013 Feb 15;85(4):497-506
pubmed: 23220537
Cell Oncol (Dordr). 2021 Feb;44(1):151-165
pubmed: 32970317
Anal Bioanal Chem. 2015 Jul;407(19):5747-58
pubmed: 25998135
Eur J Med Chem. 2018 Sep 5;157:1051-1055
pubmed: 30176535
Biochim Biophys Acta Gen Subj. 2021 May;1865(5):129842
pubmed: 33434633
Oncotarget. 2016 Jan 19;7(3):2968-84
pubmed: 26658104
ChemMedChem. 2019 Aug 6;14(15):1431-1443
pubmed: 31264794
J Biol Chem. 2013 Sep 6;288(36):25938-25949
pubmed: 23880765
Bioorg Chem. 2021 Feb;107:104577
pubmed: 33450542
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1079-C1092
pubmed: 31461341
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
PLoS One. 2015 Mar 26;10(3):e0121525
pubmed: 25811392
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1182-1191
pubmed: 30658162
Science. 2014 Jan 31;343(6170):506-511
pubmed: 24482476
J Pediatr Hematol Oncol. 2019 Nov;41(8):e484-e486
pubmed: 30951028
Cells. 2021 Jan 18;10(1):
pubmed: 33477638
Crit Rev Biochem Mol Biol. 2014 Nov-Dec;49(6):473-97
pubmed: 25418535
Mol Cancer Ther. 2019 Oct;18(10):1887-1895
pubmed: 31358663
Biochem J. 2012 Jan 1;441(1):131-41
pubmed: 21933152
Sci Rep. 2016 Jul 05;6:29264
pubmed: 27377164
J Med Genet. 2018 Aug;55(8):515-521
pubmed: 29602790
PLoS Comput Biol. 2018 Jan 29;14(1):e1005943
pubmed: 29377887
Biol Psychiatry. 2019 Jul 15;86(2):120-130
pubmed: 31097295
Orphanet J Rare Dis. 2018 Apr 24;13(1):65
pubmed: 29690908
J Exp Med. 2004 Dec 6;200(11):1395-405
pubmed: 15583013
N Engl J Med. 2011 Feb 3;364(5):432-42
pubmed: 21288095
Am J Physiol Endocrinol Metab. 2017 Jul 1;313(1):E48-E62
pubmed: 28325731
Mol Genet Metab. 2019 Apr;126(4):377-387
pubmed: 30803894
J Biol Chem. 2011 Oct 7;286(40):34567-74
pubmed: 21873433
Eur J Med Chem. 2019 Apr 15;168:28-44
pubmed: 30798051
J Med Chem. 2015 Dec 24;58(24):9680-96
pubmed: 26599519

Auteurs

Octavia Cadassou (O)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Prescillia Forey (P)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Christelle Machon (C)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.
Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69495 Pierre Bénite, France.

Edoardo Petrotto (E)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.
Dipartimento di Biologia, Unità di Biochimica, Università di Pisa, Via San Zeno 51, 56127 Pisa, Italy.

Kamel Chettab (K)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Maria Grazia Tozzi (MG)

Dipartimento di Biologia, Unità di Biochimica, Università di Pisa, Via San Zeno 51, 56127 Pisa, Italy.

Jérôme Guitton (J)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.
Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69495 Pierre Bénite, France.

Charles Dumontet (C)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.
Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69495 Pierre Bénite, France.

Emeline Cros-Perrial (E)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Lars Petter Jordheim (LP)

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH